Items where authors include "Wailoo, A."

Article

Hussain, H. orcid.org/0009-0002-5645-184X, Keetharuth, A. orcid.org/0000-0001-8889-6806, Wailoo, A. et al. (1 more author) (2025) Enhancing HRQoL assessment for economic evaluation in dementia populations. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 11 (1). e70061. ISSN 2352-8737

Hill, H. orcid.org/0000-0002-0908-5595, Rawdin, A., Wailoo, A. orcid.org/0000-0002-9324-1617 et al. (7 more authors) (2025) The clinical implications and cost-effectiveness of the provision of medical in addition to surgical catheter insertion for peritoneal dialysis in people with kidney failure. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. ISSN 0896-8608

Wickramasekera, N., Hole, A.R., Rowen, D. et al. (2 more authors) (2024) Exploring the factors that drive clinical negligence claims: stated preferences of those who have experienced unintended harm. Patient: Patient-Centered Outcomes Research, 17 (3). pp. 301-317. ISSN 1178-1653

Hernández Alava, M., Pudney, S. and Wailoo, A. orcid.org/0000-0002-9324-1617 (2023) Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study. PharmacoEconomics, 41 (2). pp. 199-207. ISSN 1170-7690

Girling, C. orcid.org/0000-0003-4216-214X, Lee, M.J., Vimalchandran, D. et al. (8 more authors) (2023) Protocol for the ORION trial (RadiO fRequency ablatION for haemorrhoids): a randomised controlled trial. Techniques in Coloproctology, 27 (2). pp. 117-124. ISSN 1123-6337

Keetharuth, A.D. orcid.org/0000-0001-8889-6806, Hussain, H., Rowen, D. et al. (1 more author) (2022) Assessing the psychometric performance of EQ-5D-5L in dementia : a systematic review. Health and Quality of Life Outcomes, 20 (1). 139. ISSN 1477-7525

Hussain, H., Keetharuth, A. orcid.org/0000-0001-8889-6806, Rowen, D. et al. (1 more author) (2022) Convergent validity of EQ-5D with core outcomes in dementia: a systematic review. Health and Quality of Life Outcomes, 20 (1). 152. ISSN 1477-7525

Peasgood, T., Mukuria, C. orcid.org/0000-0003-4318-1481, Rowen, D. orcid.org/0000-0003-3018-5109 et al. (2 more authors) (2022) Should we consider including a value for "Hope" as an additional benefit within health technology assessment? Value in Health, 25 (9). pp. 1619-1623. ISSN 1098-3015

Peasgood, T., Mukuria, C., Rowen, D. orcid.org/0000-0003-3018-5109 et al. (2 more authors) (2022) Should we consider including a value for ‘hope’ as an additional benefit within HTA? Value in Health, 25 (9). pp. 1619-1623. ISSN 1098-3015

Rowen, D. orcid.org/0000-0003-3018-5109, Wickramasekera, T., Hole, A.R. et al. (2 more authors) (2022) A discrete choice experiment to elicit general population preferences around the factors influencing the choice to make clinical negligence claims. Value in Health, 25 (8). pp. 1404-1415. ISSN 1098-3015

Gomes, M., Latimer, N. orcid.org/0000-0001-5304-5585, Soares, M. et al. (6 more authors) (2022) Target trial emulation for transparent and robust estimation of treatment effects for health technology assessment using real-world data : opportunities and challenges. PharmacoEconomics, 40 (6). pp. 577-586. ISSN 1170-7690

Rafia, R., Martyn-St James, M., Harnan, S. et al. (3 more authors) (2022) A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health, 25 (5). pp. 761-769. ISSN 1098-3015

Rowen, D. orcid.org/0000-0003-3018-5109, Mukuria, C., Powell, P. et al. (1 more author) (2022) Exploring the issues of valuing child and adolescent health states using a mixed sample of adolescents and adults. PharmacoEconomics, 40 (5). pp. 479-488. ISSN 1170-7690

Hernandez Alava, M., Wailoo, A. orcid.org/0000-0002-9324-1617, Chrysanthou, G. et al. (14 more authors) (2022) Measuring quality of life of patients with axial spondyloarthritis for economic evaluation. RMD Open, 8 (1). e001955. ISSN 2056-5933

Gray, L. orcid.org/0000-0001-6365-7710, Hernandez Alava, M. and Wailoo, A. (2021) Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer. BMC Cancer, 21 (1). 1237. ISSN 1471-2407

Scott, D.L., Ibrahim, F., Hill, H. et al. (14 more authors) (2021) Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme. Programme Grants for Applied Research, 9 (8). ISSN 2050-4322

Wailoo, A. orcid.org/0000-0002-9324-1617, Alava, M.H. orcid.org/0000-0003-4474-5883, Pudney, S. orcid.org/0000-0002-5697-0976 et al. (6 more authors) (2021) An international comparison of EQ-5D-5L and EQ-5D-3L for use in cost-effectiveness analysis. Value in Health, 24 (4). pp. 568-574. ISSN 1098-3015

Hock, E.S. orcid.org/0000-0002-8617-8875, Martyn-St James, M. orcid.org/0000-0002-4679-7831, Wailoo, A. orcid.org/0000-0002-9324-1617 et al. (6 more authors) (2021) Treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis. SN Comprehensive Clinical Medicine, 3 (3). pp. 838-854. ISSN 2523-8973

Rowen, D. orcid.org/0000-0003-3018-5109, Keetharuth, A., Poku, E. et al. (3 more authors) (2021) A review of the psychometric performance of selected child and adolescent preference-based measures used to produce utilities for child and adolescent health. Value in Health, 24 (3). pp. 443-460. ISSN 1098-3015

Scott, D., Ibrahim, F., Hill, H. orcid.org/0000-0002-0908-5595 et al. (14 more authors) (2020) The clinical effectiveness of intensive management in moderate established rheumatoid arthritis : the titrate trial. Seminars in Arthritis and Rheumatism, 50 (5). pp. 1182-1190. ISSN 0049-0172

Hernandez, M. orcid.org/0000-0003-4474-5883, Wailoo, A., Pudney, S. et al. (2 more authors) (2020) Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods. Health Technology Assessment, 24 (34). ISSN 1366-5278

Hill, J. orcid.org/0000-0002-0908-5595, Pennington, R., Wailoo, A. et al. (2 more authors) (2020) A review of the methods used to generate utility values in NICE technology assessments for children and adolescents. Value in Health, 23 (7). pp. 907-917. ISSN 1098-3015

Hernandez Alava, M., Pudney, S. and Wailoo, A. (2020) The EQ-5D-5L value set for England: Findings of a quality assurance program. Value in Health, 23 (5). pp. 642-648. ISSN 1098-3015

Griffiths, P.D. orcid.org/0000-0002-2706-5897, Bradburn, M. orcid.org/0000-0002-3783-9761, Campbell, M.J. orcid.org/0000-0003-3529-2739 et al. (13 more authors) (2019) MRI in the diagnosis of fetal developmental brain abnormalities : the MERIDIAN diagnostic accuracy study. Health Technology Assessment, 23 (49). pp. 1-144. ISSN 1366-5278

Pennington, B. orcid.org/0000-0002-1002-022X, Hernandez-Alava, M., Pudney, S. et al. (1 more author) (2019) The impact of moving from EQ-5D-3L to -5L in NICE technology appraisals. PharmacoEconomics, 37 (1). pp. 75-84. ISSN 1170-7690

Kristensen, F. B., Husereau, D., Huic, M. et al. (14 more authors) (2019) Identifying the need for good practices in Health Technology Assessment:summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. Value in Health. pp. 13-20. ISSN 1524-4733

Kristensen, F.B., Husereau, D., Huić, M. et al. (14 more authors) (2019) Identifying the need for good practices in health technology assessment: Summary of the ISPOR HTA council working group report on good practices in HTA. Value in Health, 22 (1). pp. 13-20. ISSN 1098-3015

Gray, L.A. orcid.org/0000-0001-6365-7710, Wailoo, A. and Hernandez, M. (2018) Mapping the FACT-B instrument to EQ-5D-3L in patients with breast cancer using adjusted limited dependent variable mixture models versus response mapping. Value in Health, 21 (12). pp. 1399-1405. ISSN 1098-3015

Briggs, V., Solis-Trapala, I., Wailoo, A. orcid.org/0000-0002-9324-1617 et al. (6 more authors) (2018) United Kingdom catheter study- protocol synopsis. Peritoneal Dialysis International, 38 (4). p. 314. ISSN 1718-4304

Shah, K., Tsuchiya, A. orcid.org/0000-0003-4245-5399 and Wailoo, A. (2018) Valuing health at the end of life: A review of stated preference studies in the social sciences literature. Social Science & Medicine, 204. pp. 39-50. ISSN 0277-9536

Simpson, E.L. orcid.org/0000-0001-7353-5979, Hock, E.S., Stevenson, M.D. et al. (7 more authors) (2018) What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis. Health Technology Assessment, 22 (20). ISSN 1366-5278

Cox, M., O'Connor, C., Biggs, K. et al. (17 more authors) (2018) The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation. Health Technology Assessment, 22 (11). pp. 1-204. ISSN 1366-5278

Hernandez Alava, M., Wailoo, A. orcid.org/0000-0002-9324-1617, Grimm, S. et al. (7 more authors) (2018) EQ-5D-5L versus EQ-5D-3L: the impact on cost-effectiveness in the United Kingdom. Value in Health, 21 (1). pp. 49-56. ISSN 1098-3015

Martin, N.H., Ibrahim, F., Tom, B. et al. (9 more authors) (2017) Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial. Trials, 18. 591. ISSN 1745-6215

Wailoo, A. orcid.org/0000-0002-9324-1617, Hock, E.S., Stevenson, M. orcid.org/0000-0002-3099-9877 et al. (7 more authors) (2017) The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis. Health Technology Assessment , 21 (71). pp. 1-258. ISSN 1366-5278

Grimm, S.E. orcid.org/0000-0003-1486-8233, Strong, M., Brennan, A. et al. (1 more author) (2017) The HTA risk analysis chart: visualising the need for and potential value of managed entry agreements in health technology assessment. PharmacoEconomics, 35 (1). pp. 1287-1296. ISSN 1170-7690

Griffiths, P.D. orcid.org/0000-0002-2706-5897, Bradburn, M., Campbell, M.J. orcid.org/0000-0003-3529-2739 et al. (9 more authors) (2017) Change in diagnostic confidence brought about by using in utero MRI for fetal structural brain pathology: analysis of the MERIDIAN cohort. Clinical Radiology, 72 (6). pp. 451-457. ISSN 0009-9260

Griffiths, P.D. orcid.org/0000-0002-2706-5897, Bradburn, M., Campbell, M.J. et al. (9 more authors) (2017) Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study. Lancet, 389 (10068). pp. 538-546. ISSN 0140-6736

Luqmani, R., Lee, E., Singh, S. et al. (16 more authors) (2016) The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technology Assessment, 20 (90). ISSN 1366-5278

Brown, S., Tiernan, J., Biggs, K. et al. (22 more authors) (2016) The HubBLe Trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for symptomatic second- and third-degree haemorrhoids: a multicentre randomised controlled trial and health-economic evaluation. Health Technology Assessment, 20 (88). pp. 1-150. ISSN 1366-5278

Franklin, M. orcid.org/0000-0002-2774-9439, Wailoo, A. orcid.org/0000-0002-9324-1617, Dayer, M.J. et al. (5 more authors) (2016) The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis. Circulation, 134 (20). pp. 1568-1578. ISSN 0009-7322

Stevenson, M. orcid.org/0000-0002-3099-9877, Archer, R., Tosh, J. et al. (9 more authors) (2016) Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technology Assessment, 20 (35). pp. 1-610. ISSN 1366-5278

Madan, J., Ades, T., Barton, P. et al. (9 more authors) (2015) Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party. Rheumatology and Therapy, 2 (2). pp. 113-125. ISSN 2198-6576

Hernandez Alava, M. and Wailoo, A. (2015) Fitting adjusted limited dependent variable mixture models to EQ-5D. Stata Journal, 15 (3). 737 - 750. ISSN 1536-867X

Poku, E., Rathbone, J., Wong, R. et al. (4 more authors) (2014) Safety of intravitreal bevacizumab as a monotherapy in ophthalmic conditions:systematic review. British Medical Journal Open, 4 (7). ISSN 2044-6055

Wailoo, A. orcid.org/0000-0002-9324-1617, Alava, M. H. and Escobar Martinez, A. (2014) Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D. Health and Quality of Life Outcomes, 12. 37. ISSN 1477-7525

Alava, M. H., Wailoo, A. orcid.org/0000-0002-9324-1617, Wolfe, F. et al. (1 more author) (2013) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology, 52 (5). pp. 944-950. ISSN 1462-0324

Davis, S. orcid.org/0000-0002-6609-4287 and Wailoo, A. orcid.org/0000-0002-9324-1617 (2013) A review of the psychometric performance of the EQ-5D in people with urinary incontinence. Health and Quality of Life Outcomes, 11. ARTN 20. ISSN 1477-7525

Alava, Hernanzez, M., Wailoo, A., Wolfe, F. et al. (1 more author) (2013) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis: further validation and development of the limited dependent variable, mixture model approach. Rheumatology, 2013.

Tiernan, J., Hind, D., Watson, A. et al. (5 more authors) (2012) The HubBLe trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for haemorrhoids. BMC Gastroenterology, 12. 153. ISSN 1471-230X

Hernandez, M.A., Wailoo , A., Wolfe, F. et al. (1 more author) (2012) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis: further validation and development of the limited dependent variable, mixture model approach. HEDS Discussion Paper, 12/10. (Unpublished)

Wailoo, A. orcid.org/0000-0002-9324-1617, Sutton, A. and Morgan, A. (2009) The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis. British Journal of Cancer, 100 (3). pp. 436-441. ISSN 0007-0920

Oluboyede, Y., Goodacre, S. and Wailoo, A. (2008) Cost effectiveness of chest pain unit care in the NHS. BMC Health Services Research, 8 (1). p. 174. ISSN 1472-6963

Wailoo, A., Roberts, J., Brazier, J. et al. (1 more author) (2004) NICE clinical guidelines - Health economics must engage with complexity of issues - Reply. BMJ, 329 (7465). p. 572. ISSN 0959-535X

Wailoo, A., Roberts, J., Brazier, J. et al. (1 more author) (2004) Efficiency, equity, and NICE clinical guidelines. BMJ, 328 (7439). pp. 536-537. ISSN 0959-8138

Monograph

Gray, L.A. orcid.org/0000-0001-6365-7710, Hernandez, M. orcid.org/0000-0003-4474-5883 and Wailoo, A. orcid.org/0000-0002-9324-1617 (2017) Development of methods for the mapping of utilities using mixture models: An application to asthma. Working Paper. ScHARR HEDS Discussion Papers, 17.03 . School of Health and Related Research , University of Sheffield.

Hernández Alava, M. and Wailoo, A. (2010) Multilevel modelling of cost data: an application to thrombolysis and primary angioplasty in the UK NHS. Discussion Paper. (Unpublished)

Wailoo, A., Tsuchiya, A. and McCabe, C. (2009) Weighting must wait: incorporating equity concerns into cost effectiveness analysis may take longer than expected. Discussion Paper. Pharmacoeconomics

Goodacre, S., Sampson, F.C., Stevenson, M. et al. (5 more authors) (2006) Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. Technical Report. Gray Publishing , Tunbridge Wells.

Claxton, K., Eggington, S., Ginnelly, L. et al. (5 more authors) (2005) A pilot study of value of information analysis to support research recommendations for NICE. Research Report. CHE Research Paper (4). Centre for Health Economics , York, UK.

Proceedings Paper

Metry, A. orcid.org/0000-0001-7412-6093, Rafia, R. and Wailoo, A. orcid.org/0000-0002-9324-1617 (2022) EE315 Economic evaluation of neutralising monoclonal antibodies for the treatment of COVID-19 positive people in the community. In: Value in Health. ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington, DC, USA. Elsevier BV , S395-S396.